tirzepatide weight loss timeline percentages as Compared with Semaglutide for the Treatment of Obesity Monthly GLP-1 for Weight Maintenance

In a review of clinical trials lasting over a year published in The American Journal of Cardiology, adults taking weekly injections lost on average about 12% of their body weight, and about one-third of participants lost 20% or more of their starting weight

We know when we manage our patients with type 2 diabetes, we not only need to be concerned about glycemic control, but also about reducing cardiometabolic risk as well as weight reduction since most of our patients are overweight or obese, Juan P

J Clin Psychiatry 2017;78:14-19

This is usually related to blood sugar shifts and often resolves once glucose stabilizes